Mead Johnson Nutrition CO  

(Public, NYSE:MJN)   Watch this stock  
Find more results for MJN
-1.59 (-1.59%)
Jan 23 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 98.19 - 100.00
52 week 73.23 - 104.89
Open 100.00
Vol / Avg. 0.00/1.19M
Mkt cap 19.87B
P/E 27.96
Div/yield 0.38/1.53
EPS 3.52
Shares 202.10M
Beta 0.70
Inst. own 94%
Jan 29, 2015
Q4 2014 Mead Johnson Nutrition Co Earnings Release - 9:30AM EST - Add to calendar
Jan 29, 2015
Q4 2014 Mead Johnson Nutrition Co Earnings Call - 9:30AM EST - Add to calendar
Nov 18, 2014
Mead Johnson Nutrition at Morgan Stanley Global Consumer Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 17.26% 15.59%
Operating margin 22.24% 22.01%
EBITD margin - 26.15%
Return on average assets 19.36% 19.46%
Return on average equity 159.27% 417.58%
Employees 7,200 -
CDP Score - 85 B


GLENVIEW, IL 60026-8039
United States - Map
+1-847-8322420 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children's nutrition and other nutritional products. Its Enfa family of brands, including Enfamil infant formula, is the global brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers, health care professionals and retailers in more than 50 countries in Asia, North America, Latin America and Europe. In addition to the Enfa family of brands, the Company markets several other brands on a local, regional or global basis. These brands complement the Enfa family of brands portfolio, such as Nutramigen or the nutritional needs of broad consumer populations, such as ChocoMilk and Cal-C-Tose.

Officers and directors

Peter Kasper Jakobsen President, Chief Executive Officer, Director
Age: 52
Bio & Compensation  - Reuters
Peter G. Leemputte Chief Financial Officer, Executive Vice President
Age: 57
Bio & Compensation  - Reuters
William C. P'Pool Senior Vice President, Secretary
Age: 49
Bio & Compensation  - Reuters
James Jeffrey Jobe Senior Vice President - Technical Operations
Age: 55
Bio & Compensation  - Reuters
Charles M. Urbain Senior Vice President - Stakeholder Relations & Chief Development Officer
Age: 60
Bio & Compensation  - Reuters
Dirk Hondmann Ph.D. Chief Scientific Officer
Age: 50
Bio & Compensation  - Reuters
Tom De Weerdt Vice President, Corporate Controller
Age: 41
Bio & Compensation  - Reuters
James M. Cornelius Non-Executive Chairman of the Board
Age: 71
Bio & Compensation  - Reuters
Robert Singer Lead Independent Director
Age: 62
Bio & Compensation  - Reuters
Stephen W. Golsby Director
Age: 59
Bio & Compensation  - Reuters